Common Contracts
3 similar Note Purchase Agreement contracts by Cyclo Therapeutics, Inc.
THIRD AMENDED AND RESTATED NOTE PURCHASE AGREEMENTNote Purchase Agreement • September 9th, 2024 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
THIS THIRD AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of September 9, 2024 (the “Amendment Effective Date”), is entered into by and among CYCLO THERAPEUTICS, INC., a Nevada corporation (the “Company”), and RAFAEL HOLDINGS, INC., a Delaware corporation (the “Investor”).
SECOND AMENDED AND RESTATED NOTE PURCHASE AGREEMENTNote Purchase Agreement • August 22nd, 2024 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
THIS SECOND AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of August 21, 2024 (the “Amendment Effective Date”), is entered into by and among CYCLO THERAPEUTICS, INC., a Nevada corporation (the “Company”), and RAFAEL HOLDINGS, INC., a Delaware corporation (the “Investor”).
SECOND AMENDED AND RESTATED NOTE PURCHASE AGREEMENTNote Purchase Agreement • August 22nd, 2024 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
THIS SECOND AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of August 21, 2024 (the “Amendment Effective Date”), is entered into by and among CYCLO THERAPEUTICS, INC., a Nevada corporation (the “Company”), and RAFAEL HOLDINGS, INC., a Delaware corporation (the “Investor”).
